期刊文献+

4-(4-取代苯胺基)-2-取代苯基-喹唑啉类衍生物对H_9C_2心肌细胞肥大的影响

Effects of 4-(4-substituted aniline)-2-substituted phenyl quinazoline derivatives on cardiac hypertrophy in H_9C_2 cells
原文传递
导出
摘要 目的:研究4-(4-取代苯胺基)-2-取代苯基-喹唑啉类衍生物[4-(4-substituted aniline)-2-substituted phenyl quinazoline derivatives,Q]对血管紧张素Ⅱ(angiotensinⅡ,AngⅡ)诱导的H_9C_2心肌细胞肥大的影响。方法:体外培养H_9C_2细胞株,将培养的H_9C_2心肌细胞随机分为正常组(Con组),AngⅡ组,AngⅡ+Q高剂量(10-6 mol/L)组、AngⅡ+Q中剂量(10-7 mol/L)组、AngⅡ+Q低剂量(10-8 mol/L)组,采用激光共聚焦技术对H_9C_2细胞的形态扫描成像,利用计算机进行图像处理,对H_9C_2细胞表面积进行定性定量分析,BCA法测定蛋白浓度,MTT法测定加入不同浓度喹唑啉衍生物后心肌细胞活性,以及通过RT-PCR发测定肥大相关基因mRNA的表达。结果:与Con组相比,AngⅡ刺激H_9C_2心肌细胞后,细胞表面积明显增大(P<0.05);加入喹唑啉衍生物后,H_9C_2心肌细胞表面积明显减小(P<0.05)。AngⅡ诱导的H_9C_2心肌细胞,其总蛋白含量和肥大相关基因mRNA的表达水平都明显高于正常的H_9C_2心肌细胞(P<0.05),加入喹唑啉衍生物处理后的H_9C_2心肌细胞其肥大相关基因mRNA的表达明显下降(P<0.05)。结论:4-(4-取代苯胺基)-2-取代苯基-喹唑啉类衍生物可以改善AngⅡ诱导的H_9C_2心肌细胞肥大。 Objective:To define the effects of 4-(4-substituted aniline)-2-substituted phenyl quinazoline derivatives on cardiac hypertrophy.Method:The establishment of cardiomyopathy hypertrophy model through stimulatingH_9C_2 cells with AngⅡ.H_9C_2 cells were randomized into five groups:normal control group;AngⅡgroup;AngⅡ+Q group(10-6 mol/L);AngⅡ+Q group(10-7 mol/L);AngⅡ+Q group(10-8 mol/L).The surface area ofH_9C_2 was measures with a laser scanning confocal microscope technique(LSCM).The total protein content was analyzed by BCA.The survival of cells was assayed by MTT,and the mRNA expressions of hypertrophy-related genes were detected by RT-PCR.Result:Compared with control group,the surface area ofH_9C_2 stimulated by AngⅡ was increased significantly(P〈0.05),after joining Q,the surface area decreased observably(P〈0.05).The level of total protein and expressions of genes of hypertrophy ofH_9C_2 stimulated by AngⅡ was increased apparently(P〈0.05),however,those indicators were declined comparatively ofH_9C_2 handled by Q(P〈0.05).Conclusion:Quinazoline compound can perfect AngⅡ-induced cardiomyopathy hypertrophy.
机构地区 广东医科大学
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2018年第1期74-77,共4页 Journal of Clinical Cardiology
基金 广东医科大学科研基金(No:M2016020)
关键词 心肌肥大 4-(4-取代苯胺基)-2-取代苯基-喹唑啉类衍生物 血管紧张素Ⅱ cardiac hypertrophy 4-(4-substituted aniline)-2-substituted phenyl quinazoline derivatives angiotensin Ⅱ
  • 相关文献

参考文献1

二级参考文献9

  • 1GANDY S, DEKOSKY S T. Toward the treatment and prevention of Alzheimer's disease:Rational strategies and recent progress[J]. Annu. Rev. Med. , 2013,64 ( 1 ) : 367- 383.
  • 2HARDY J A, SELKOE D J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics [J]. Science, 2002,297 ( 5 580) :353-356.
  • 3ABBOTT A. Dementia: a problem for our age [J]. Nat. , 2011,475(7 355) :S2-4.
  • 4ANAND R, GILL K D, MAHDI A A. Therapeutics of Alzheimer's disease: Past, present and future [J]. Neuro- pharmacology, 2014,76 : 27 -50.
  • 5LAMMICH S, KAMP F, WAGNER J, et al. Translational repression of the disintegrin and metalloprotease AD- AMI0 by a stable G-quadruplex secondary structure in its 5 '-untranslated region[J]. J. Biol. Chem. , 2011,286 (52) :45 063-45 072.
  • 6MARK J,MORRISL K L,SOUMITRA B,et al. The por- phyrin TmPyP4 unfolds the extremely stable G-quadru- plex in MT3-MMP mRNA and alleviates its repressive effect to enhance translation in eukaryotic cells [J]. Nu- cleic Acids Res. ,2012,40(9) :4 137-4 145.
  • 7ZOE A E W',SVEN A S,SHANKAR B,et al. A small molecule that disrupts G-quadruplex DNA structure and enhances gene expression[J]. J. Am. Chem. Soc. ,2009, 131(35) :12 628-12 633.
  • 8DIMITRY K, NIKOLAY I, ANDREI S, et al- Disordering of human telomerie G-quadruplex with novel antiprolifer- ative anthrathiophenedione [J]. PLOS ONE, 2011, 6 (11) :e27 151.
  • 9JYOTIRMAYEE D,ZOE A E W, SHANKAR B, et al. Synthesis and binding studies of novel diethynyl-pyridine amides with genomic promoter DNA G-quadruplexes[J]. Chem. Eur. J. ,2011,17(16) :4 571-4 581.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部